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ABSTRACT
Introduction: The size and composition of the
European Union healthcare workforce are key drivers of
expenditure and performance; it now includes new
health professions and enhanced roles for established
professions. This project will systematically analyse
how this has contributed to health service redesign,
integration and performance in 9 European countries
(Scotland, England, Netherlands, Germany, Italy, Czech
Republic, Poland, Norway, and Turkeyi). This paper
describes the protocol for collection of survey data in 3
distinct care pathways, and sets it in the context of the
wider programme.
Methods: Questionnaires will be distributed to
healthcare professionals (n=14 580), managers
(n=3564) and patients (n=19 440) in 3 care pathways
(breast cancer; type 2 diabetes; and coronary heart
disease) within 12 hospitals and associated primary
care settings in each country. Questionnaire topics will
include demography, the different professionals
working on the care pathway, the tasks they do and the
time taken, their decision-making abilities when
considering skill mix, specialisation and integration of
care. Patient satisfaction, healthcare utilisation and
preferences will be explored. In later work, register data
and data from patient records will be used to record
clinical outcomes. Data will also be collected on
workforce and procedure costs. Descriptive analysis
will identify the different models of care and
multivariate analysis will establish the most clinically
and cost-effective models.
Ethics and dissemination: This protocol was
approved by ethical committees in each country.
Findings will be disseminated through national/
international clinical, health services research and
health workforce conferences, and publications in
national/international peer-reviewed journals.
INTRODUCTION
Background and rational
Workforce is the largest single component of
healthcare expenditure in European Union
(EU) member states.1 The size and compos-
ition of the healthcare workforce are key
drivers of both expenditure levels and the
performance of healthcare systems. Both the
size and composition of the healthcare work-
force are changing in many European coun-
tries in response to measures to contain
healthcare expenditures, changing needs for
healthcare, and changing working patterns
(eg, feminisation of the workforce, with
increasing demands of childcare and the
move towards part time working, and imple-
mentation of working time legislation).
In a number of countries there have also
been substantial innovative developments in
health workforce skills. New health profes-
sions have been introduced (eg, physician
associates (PAs)2) and enhanced roles for
established professions (such as nurses, and
pharmacists) have been developed.3 4 The
term ‘new professional roles’ is used in the
remainder of this paper to describe both
these scenarios. New professional roles
potentially lead to the delegation of care
from doctors to other healthcare profes-
sionals (in which case the doctor may still
retain a supervisory role and remains respon-
sible for the overall care of the patient5) and
the substitution of roles (in which a profes-
sional, such as a nurse prescriber,6 assumes
full responsibility for a task (prescribing)
previously the preserve of a doctor). Both of
these have further ramiﬁcations as care previ-
ously delivered by, for example, a nurse is
now delivered by a healthcare assistant.7 New
professional roles have the potential to con-
tribute to increased effectiveness and
iTurkey straddles both Europe and Asia; it is an associate
country of the EU, and accession negotiations for full
membership are ongoing. For the purposes of this
research, Turkey is referred to as a European country
while recognising that geographically, some data will be
collected from locations in Asia.
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efﬁciency in service delivery,8–11 and mapping the skills
and competencies of the health workforce has been
identiﬁed as one of the key areas for action by the
European Commission (EC).12 As new professional
roles become more universal, current approaches to
workforce planning will need to be adapted to include
these new models of service delivery. Furthermore, at a
time when integrated care is regarded as a quality
marker, it is important to understand how it is affected,
if at all, by the deployment of an increasingly diverse
workforce.
This paper describes the protocol for surveys, in nine
countries, which are part of a wider programme of work
entitled Health Care Reform: The iMpact on practice,
oUtcomes and costs of New roles for health pROfeSsionals
(MUNROS: http://www.abdn.ac.uk/munros). The ultim-
ate aim of the MUNROS programme is to inform a work-
force planning model based on integrated ﬁnancial and
health service planning, and the competencies needed to
deliver care, rather than professional qualiﬁcations. The
programme will systematically study the workforce issues
described above in primary and secondary healthcare set-
tings—along the three clinical pathways for breast cancer,
type 2 diabetes and coronary heart disease following an
ST segment elevation myocardial infarction (STEMI)—
in nine European countries (Scotland, England,
Netherlands, Germany, Italy, Czech Republic, Poland,
Norway, and Turkeyi). The design of the overall MUNROS
programme is observational and cross-sectional, combin-
ing the questionnaire surveys described in this paper
(including a patient-completed discrete choice experi-
ment (DCE)) with patient-level, hospital-level and country-
level data on clinical outcomes as available from routinely
held databases, and unit costs of care consumption.
Economic modelling using multicriteria decision analysis
(MCDA) will inform a ﬁnal synthesis to identify optimal
models of care and distinguish the critical elements of
these models. The ﬁndings will be incorporated into a
generic multiprofessional workforce planning tool; this
will be developed by mapping the tasks performed to the
skills and competences required to undertake these tasks,
alongside estimates of projected patient need. In each
partner country, a Country Expert Advisory Group
(CEAG) has been convened to support and advise the
project. The study is also advised by an international
Expert Advisory Board (EAB).
There were three pieces of work undertaken in earlier
stages of the MUNROS programme which informed the
development of the surveys. First, the key features of the
health delivery systems in the nine countries of study
were detailed through analysis of routinely collected data
from international and national statistical ofﬁces and
national health services, and a systematic review of pub-
lished research, policy documents and grey literature was
conducted.3 Second, again using routinely available data,
the skill mix of the health workforce in the primary and
secondary care sectors in all European countries was
detailed, and then details of new professional roles and
the numbers working in them in each sector in the nine
partner countries were described.
Following this high-level analysis, three clinical condi-
tions were selected for more in-depth study in the
remainder of the programme. The conditions were
selected from a list generated in the earlier scoping
work in the nine partner countries that identiﬁed the
clinical areas in which the new professional roles were
employed. This list was supplemented with suggestions
from clinical managers and workforce managers who
were members of each partner’s CEAG and the inter-
national EAB. A 2-day face-to-face meeting of a
stakeholder group comprising invited expert representa-
tives from the medical and non-medical healthcare pro-
fessionals, primary and secondary care settings,
managers and patients reviewed, scrutinised and made
additions to the list of potential conditions and agreed
selection criteria (box 1).
Applying the criteria resulted in four clinical conditions
and associated care pathways being identiﬁed: hip replace-
ment/hip fracture, breast cancer, type 2 diabetes and cor-
onary heart disease following a STEMI. These four were
then assessed by each of the nine partner countries for use
of new healthcare professionals and availability of routine
data (required for assessment of clinical outcomes). As a
result of this, hip replacement/hip fracture was excluded.
The ﬁnal three clinical conditions can be considered,
respectively, as examples of: a condition requiring a
scheduled surgical intervention, postoperative and
follow-up care; a long-term condition managed largely
in primary care, but with support from secondary care; a
condition presenting acutely and requiring unscheduled
hospital care, rehabilitation and long-term care. The
care pathways for each of these conditions were then
Box 1 Clinical criteria for selection of care pathways
▸ The clinical condition is of high prevalence, significant mor-
bidity and mortality are associated with the condition, and
data on these exist (ie, a burden to society)
▸ Data exists on health outcomes that are related to new profes-
sional roles and/or the integration of care: outcomes of pro-
cesses (eg, patient follow-up and integration of care, patient
satisfaction), intermediate health outcomes (eg, clinical health
outcomes, avoided complications), and final outcomes of care
(eg, patient quality of life)
▸ Procedures and clinical management are similar across differ-
ent national boundaries
▸ Care could be delivered by a range of health professionals—in
at least some of the partner countries care is delivered by
either new professions or new roles for existing professions.
The contribution of different professions varies across
partners
▸ Patients have a role in managing the condition
▸ Care is delivered in primary and secondary settings, and desir-
ably in intermediate and tertiary care settings. Overall, at least
one care pathway will have a substantial presence in primary
care setting while another one will have a substantial presence
in a secondary care setting
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identiﬁed as the clinical context for all subsequent
research.
Following selection of the pathways, case studies were
conducted. The case studies sought to understand the
new professional roles that were being delivered, the
mechanisms and drivers for greater skill mix in the deliv-
ery of care, and the delegation of tasks from medical to
other members of the healthcare team. Eight of the
nine partners conducted case studies in two care path-
ways that were selected to ensure that across the part-
ners, several case studies were conducted in each of the
three pathways.
Objectives of the surveys
The overall aim of the surveys is to describe and quantify
the use of new professional roles in primary and second-
ary care sectors in three care pathways in nine European
countries, to understand their effects on the quality of
care, and on the delivery of integrated care. Later stages
of the project will evaluate their clinical and cost effect-
iveness; select the most effective and efﬁcient service
models as benchmarks; and develop a workforce plan-
ning tool based on the competencies required to meet
population needs.
METHODS
Conceptual framework
The MUNROS project researches the relationship
between the inputs to the health service, focusing in par-
ticular on the staff input, and the outputs of the health
service, focusing on patient outcomes. Where the focus of
research is on the quantity and mix of different types of
staff, rather than by institution, the appropriate concep-
tual framework is that of a production function employed
in economics. Thus, the relationship which is the focus of
the research can most concisely be deﬁned as:
OiPH1;C ¼ f(LPH1C;K) ð1Þ
Equation (1) states that clinical outcomes for a sample of
patients, i (where i=1…N), in receipt of treatment along
care pathway P, in hospital H1, in country C, results from
the activities of the workforce, identiﬁed by L, in pathway P,
at hospital H1, in country C together with all the other
non-staff inputs for care, here deﬁned by K.
The project design seeks to distinguish hospitals which
employ new professions and those which employ both
new and established professions within the same care
pathway. Using the above notations, it seeks to distinguish
a hospital H1 in which only established professions, L1,
are employed and a second hospital H2 in which both
established professions, L1, and new professions, L2, are
employed. A comparison of the clinical outcomes for
patients along this pathway in these two hospitals, as in
equation (1) (above) and equation (2) (below) will then
distinguish the impact of employing new professions.
OiPH2C ¼ fðL1PH2C; L2PH2C;KÞ ð2Þ
The advantages of this speciﬁcation are that it:
1. Controls for heterogeneity in the clinical outcome
mix, O, by moving from the health service as a whole
to deﬁned care pathways identiﬁed in the earlier devel-
opmental work. Measures of clinical output which
are speciﬁc to the patients treated along each
pathway will be obtained.
2. Captures differences in service design which result in
differences in staff mix.
3. Controls for heterogeneity in patient characteristics, i,
by obtaining details of a wide range of characteristics
in the patients’ questionnaire and through the use of
vignettes in the health professionals’ questionnaires.
These vignettes present respondents with a standar-
dised clinical episode: a patient presenting at a par-
ticular stage in the pathway with a highly speciﬁc
condition which requires treatment and which is
accompanied by a speciﬁc set of comorbidities. This
eliminates the issue of unmeasured comorbidities in
this speciﬁc treatment group.
4. Clinical protocols reduce heterogeneity in other inputs
to health outcomes, as indicated by K, for these
determine the management of the disease by pre-
scribing the procedures, drugs and technologies used
in treatment.
The core of the surveys requires health professionals,
managers and patients to identify who does what at each
stage along the three care pathways. The tasks needed to
deliver care along each pathway, and the professional(s)
undertaking those tasks will be identiﬁed together with
actual and potential substitutions. When associated
ultimately with cost and clinical output data, it will
enable the identiﬁcation of the most efﬁcient combin-
ation of skills and competencies to achieve a given level
of clinical output, or the combination of skills and com-
petencies that will achieve the highest level of clinical
output for a given cost.
Study design
This is a cross-sectional survey using self-completed ques-
tionnaires, either distributed by post or handed out at
staff meetings or patient clinics for three speciﬁc care
pathways (breast cancer, type 2 diabetes and coronary
heart disease following a STEMI).
Study setting
The study setting is 12 hospitals and 60 associated
primary care centres (average 5 per hospital) in each of
the nine countries. Careful selection of hospitals enables
us to reduce unmeasured heterogeneity. It is reasoned
that similar types of hospitals are likely to employ the
same technology. Thus, teaching hospitals are likely to
employ some of the latest technology available to the
health service and are more likely to be engaged in
research with associated funding opportunities for new
developments. Large hospitals may have similar volumes
of throughput along a care pathway (assuming that
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volume of throughput is one determinant of the quality
of clinical outcomes).
Countries were selected to reﬂect the diversity of
systems in Europe and the different stages of reform
of healthcare systems. They include those: in the later
stages of transition from highly centralised (ex-commun-
ist) systems (Czech Republic and Poland), at the fore-
front of innovation of delivery systems (Netherlands,
Scotland and England), with more established and
stable systems (Germany, Italy and Norway), and a
rapidly developing country (Turkey).
Participants and eligibility
There are two categories of participants who will be
identiﬁed and recruited from a participating hospital or
general practice.
Healthcare professionals and managers: All healthcare pro-
fessionals providing care to patients within one of the
three selected care pathways—from the point of diagno-
sis to long-term follow-up—will be invited to take part,
together with all healthcare managers responsible for
decision-making about the workforce providing care for
these patients.
Patients: A random sample of patients within one of
the three selected care pathways will be eligible to take
part as long as they meet the following inclusion criteria:
▸ Male or female patients aged 21 years and over (note
there is no upper age limit);
▸ Receiving care in one of the three care pathways:
breast cancer; type 2 diabetes; and coronary heart
disease;
▸ Having capacity to understand the purpose of the
study and complete the questionnaire.
In addition, the following disease-speciﬁc inclusion cri-
teria will be applied:
▸ Patients with coronary heart disease—have suffered a
STEMI, are stabilised (ie, may still be in initial hos-
pital admission) or up to 2 years in follow-up;
▸ Patients with breast cancer—have been diagnosed
and received some treatment for breast cancer, and
are between 3 months and 2 years post-surgery;
▸ Patients with type 2 diabetes—have been diagnosed
with type 2 diabetes and are at least 3 months post
diagnosis to 2 years in follow-up.
Identification and recruitment of sites and participants
Hospitals and primary care centres
Hospitals vary by type, location, size and population
served, and the organisation within which they are
managed. All of these factors may inﬂuence the extent
to which new healthcare professionals/new professional
roles are employed in the care of patients. Identiﬁcation
and recruitment of the hospitals will be based on the fol-
lowing procedure adapted to local circumstances so as
to ensure representation of each of these factors. Thus,
all hospitals in each country will be listed, and the list
stratiﬁed by: type (teaching hospitals and general hospi-
tals), geographical region, rurality (urban, suburban or
rural), and sociodemographic characteristics of the
catchment area (deprived and less deprived). Eligible
hospitals will be invited to consider taking part by
mailing an invitation pack (covering letter, participant
information sheet, and expression of interest form) to
hospital directors or their delegated deputy. From those
expressing interest, 12 hospitals will be selected accord-
ing to the criteria outlined above under ‘Study setting’
section. Hospital consent to participate will obtained by
mailing invitation packs (covering letter, participant
information sheet, and consent forms) either to hospital
directors or clinical leads for each condition (or as
appropriate in non-UK countries) according to prefer-
ence of hospital. Ideally hospitals should be providing
care along two of the three selected care pathways.
Primary care centres associated with each hospital will
be similarly selected. All primary care providers in the
catchment area of the recruited hospitals will be con-
tacted by mail with an invitation pack (covering letter,
participant information sheet, and expression of interest
forms) and from those expressing interest, a maximum
variation sample of average ﬁve (and a maximum of 60
per country) will be purposively selected to give repre-
sentation of different types, locations and socioeconomic
factors (eg, deprived and wealthier communities, differ-
ent ethnicities).
Healthcare professionals and managers
Within each clinical team (ie, the team providing care
to people with one of the three conditions) at each hos-
pital a key contact will be identiﬁed. This is likely to be
the clinical lead. They will advise on the best method of
questionnaire distribution. Invitation packs (covering
letter, participant information leaﬂet (PIL), and ques-
tionnaire) will be sent to identiﬁed participants using
one or a combination of the following methods tailored
to national and local arrangements: (1) where names
are in the public domain, participants may be contacted
directly by the researchers; (2) where this is not possible,
key contacts or their depute will inform their team
about the study and ask those interested in participating
to send their contact details to the researchers so that
the questionnaire packs can be mailed directly; (3) alter-
natively, key contacts will distribute questionnaires on
behalf of the researchers, with a request to mail the
completed questionnaire back to the researchers in a
reply-paid envelope and (4) ﬁnally, face-to-face launch
meetings will be arranged at each site, and a member of
the research team will give a short summary of the
purpose and structure of the project, encourage partici-
pation, and distribute questionnaires to those attending
the meeting. All questionnaires will be identiﬁed with a
secure identiﬁcation number that is linked to the iden-
tity of the recipient, and recorded on a paper log that
will be subsequently transcribed to an electronic log.
This will allow up to two targeted reminders to be sent
to non-responding healthcare professionals and man-
agers by clinical managers/link people.
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The ﬁrst three of the above four approaches will be
adopted in primary care centres. Where there is no
primary care doctor with a special interest in one of the
three conditions, speciﬁc questionnaires will be ran-
domly allocated.
Patients
For each care pathway, patients meeting the inclusion
criteria will be identiﬁed either prospectively as they
present in clinic or from clinic lists, according to local
preference. Those identiﬁed in the clinic will be handed
an invitation pack (covering letter, PIL, and question-
naire) by the responsible clinician. They will be encour-
aged to complete the questionnaire while waiting for
their appointment. Patients will be asked to complete
and return the questionnaires directly to the researchers
via a box in the clinic or mail it directly in a reply-paid
envelope. Those identiﬁed from clinic lists will be
mailed the invitation pack by the clinical staff or their
designated representative. A log of patients given the
questionnaire, and their contact details will be main-
tained by clinic staff to allow response rates to be
assessed and one reminder to be sent to non-
responders.
Sample size
In each country, 12 hospitals will be selected and there-
after, three care pathways within each of these hospitals;
this gives 36 care pathways and a total of 324 (36×9) care
pathways across all partners. We estimate that the
average number of healthcare professionals on a
pathway will be 30 giving a total of 9720 questionnaires
distributed (324×30) to healthcare professionals across
all partners. We further estimate that there will be an
average of 6 healthcare managers per pathway giving a
total of 1944 (6×324). There will be 540 (60×9) primary
care centres taking part with an estimated 4860 (9×540)
questionnaires distributed to healthcare professionals
across all partners, and 1620 (3×540) questionnaires dis-
tributed to healthcare managers. The above distribution
is designed to generate a sample large enough to
capture representation of a range of site characteristics
likely to affect workforce diversiﬁcation while recognis-
ing the differences between the three clinical
conditions.
Using the procedures described above and by extrapo-
lating from researchers’ recent experience,13 we estimate
a 40% response rate to the health professional and
manager questionnaires, thus giving a total of 5832 and
1425 returned health professional and manager ques-
tionnaires, respectively.
Patient recruitment will continue at each of the 324
hospitals until 30 patients have been approached in total
per condition, and at each primary care centre until an
average of six patients per centre have been approached
per condition (or 30 per hospital area). With an esti-
mate of a 50% response rate (based on recent work of
the applicants14), this will produce 9720 completed
patient questionnaires. These numbers are judged sufﬁ-
cient to allow estimation of the main outcomes, and
facilitate comparison of the main outcomes by country
and condition.
Data collection
Data collection will close at the end of 2015.
Questionnaires
Three questionnaires, each with three versions tailored to
the three care pathways, were designed to be completed
by: (1) healthcare professionals; (2) healthcare managers
of these professionals; (3) patients receiving care from
these professionals. A fourth questionnaire, a DCE survey
was sent to patients who had agreed in (3) to participate
further. Draft questionnaires were developed, in English,
by an expert group drawn from those partners with the
most extensive research experience in the area.
Questionnaires were translated and validated through back
translation into each of the partner country languages.
Final versions of the questionnaires (1) to (3) above
were agreed after feedback from partners and the
CEAG, pre-pilots with local colleagues and a formal pilot
in which each country piloted the three questionnaires
in one hospital for two of the three target conditions
(∼20 healthcare professionals, 3 healthcare managers
and 5 patients). Where available, standard instruments
and scales have been incorporated. The resource use
questions are based on those developed in and widely
applied in other research undertaken by partners.
Overall design drew on the Cochrane review,15 and uses
methods known to encourage high response rates.
The questionnaires are as follows:
Healthcare professional questionnaire: This question-
naire includes sections on respondent demography,
roles, and education (closed questions), who they
work with (ﬁxed choice options based on a list gener-
ated in consultation with local clinical colleagues to
ensure all those providing healthcare along the care
pathway are included, and including an ‘Other’
option), the tasks undertaken at different stages of the
care pathway (based on detailed discussions with local
clinical colleagues), the frequency with which these
are undertaken and the time taken for both a standar-
dised patient based on a vignette and for a patient
they would typically treat (combination of yes/no
questions and open responses), their opportunity to
undertake new roles, the barriers and facilitators to
undertaking new roles (combination of yes/no ques-
tions, Likert scales and open responses), the drivers
for new roles (combination of yes/no questions, Likert
scales and open responses), the integration16 and spe-
cialisation of care on the relevant care pathway, and
whether care was seen as being team based or doctor
led.
Healthcare manager questionnaire: The healthcare
manager questionnaire was constructed in a similar
manner to the healthcare professional questionnaire,
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and includes sections on respondent demography,
roles, and education (closed questions), the staff they
manage (ﬁxed choice options, as above), the tasks
undertaken at different stages of the care pathway by
different professionals (ﬁxed choice options), the
inﬂuences on their decision-making about stafﬁng
changes in the mix of staff working on the relevant
care pathway (Likert scales), the drivers for these
(combination of yes/no questions, Likert scales and
open responses), and the integration16 and specialisa-
tion of care on the relevant care pathway.
Patient questionnaire: The patient questionnaire
includes sections on: the patient’s health including
conﬁrmation of eligibility, the Charlson Index for
comorbidities17 and the EQ5D-5L as a quality-of-life
instrument,18 the care they have received and the pro-
fessionals who provided the care (tick box yes/no
options), their experience of care (Likert scale
responses to a series of statements), their satisfaction
with care (Likert scale responses to various parameters
of care), and their perceptions of the importance of
speciﬁc characteristics of care, continuity of care and
how care was organised (team based or doctor led),
their use of healthcare services and who they saw (tick
box and open questions), the value they place on
their care (a willingness to pay question), demo-
graphic questions (age, weight, education, employ-
ment, income, lifestyle), and effect of condition on
daily life. A ﬁnal question asks them to provide
contact details if they would be willing to be contacted
again for subsequent stages of the research.
DCE: A fourth questionnaire, a DCE survey,
will explore patients’ preferences and trade-offs for
different aspects of care. The questionnaire will elicit
preferences for treatment by new healthcare profes-
sionals compared to traditional approaches. The DCE
will be sent to those patients who in the initial ques-
tionnaire give their consent to be contacted about
further research and provide contact details. The attri-
butes and levels will be based on the literature and the
responses to relevant items in the patient question-
naire. Based on pilot data, these are likely to be as
shown in ﬁgure 1. The respondents will be asked to
imagine a scenario in which their acute condition has
been stabilised and they are in follow-up care. The
questionnaire will also include questions to conﬁrm
eligibility, basic demographic questions (sex, date of
birth, household members, educational level, house-
hold income), and questions about the way they have
completed the choice sets, their attitudes to health,
their health status (excellent, very good, good, fair
poor), their health expectations in the next 2 years if
they have and do not have follow-up care, the import-
ance of each of the attributes to them (rated from 1,
not important to 5 very important), and their willing-
ness to pay for an ideal follow-up visit. The DCE will
be distributed by mail or email according to national
preferences and one reminder will be sent.
Outcomes
The survey outcomes are a description of the:
▸ Healthcare professionals involved in the delivery of
care;
▸ Tasks on the care pathway, the frequency with which
these are delivered and by whom;
▸ Patients’ expectations, experiences, and preferences
for care;
▸ Integration of care;
▸ Drivers for skill-mix changes in the team delivering
care.
Data management and analysis
Data from returned questionnaires will be entered into an
Excel spreadsheet by each partner following agreed data
coding rules and data cleaning protocols (eg, for missing
data). Double data entry on 10% of returned question-
naires will be used to check for accuracy. The ﬁnal data set
will be exported into a STATA database for analysis, using a
standard syntax and according to an a priori data analysis
plan agreed to by all partners. Any identifying data (eg,
hospital name, care pathway) will be anonymised by
coding to allow for clustering in the analyses while main-
taining conﬁdentiality. Where terms for different health-
care professionals vary in the different partner countries,
these will be coded to internationally recognised high-level
categories (eg, consultant doctor, junior doctor, nurse,
advanced practice nurse). Partners will hold country-level
databases and a cross-country data set will be created for
Europe wide analyses to be led by named researchers (ie,
the database will not be made generally available to the
whole team). Data will be stored securely on password-
protected computers and a single study Master File stored
on a shared drive (Sharepoint).
Initial analyses will include simple descriptive frequen-
cies, and associations between dependent and independ-
ent variables using appropriate multivariate techniques.
The pooled country database will be analysed using
multivariate and multilevel modelling methods, and
made available to partners to undertake an agreed plan
of analysis. Country-speciﬁc and intercountry analyses
will model the relationships between the central depend-
ent and independent variables as speciﬁed in equations
(1) and (2) of the conceptual framework, within and
across countries. Analysis of the results of the DCEs will
distinguish how the preferences of respondents for dif-
ferent care pathways are to be measured and weighted,
and what intercountry differences exist.
PLANNED WORK TO FOLLOW THE QUESTIONNAIRES
Additional outcome measures not collected by the
patient questionnaires will be extracted from register
data at the hospital and/or national level; the data
source will vary by country because of different clinical
recording systems and health service systems. These data
will include standard relevant health and healthcare
indicators (eg, morbidity and mortality), and measures
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of patient safety, patient turnover, length of inpatient
stay, and number of readmissions. Process productivity
will then be calculated, measured as consultation times
per type of professional and consultation rates per hour.
The data will also be used to assess the representative-
ness of the survey respondents compared with the wider
hospital population of patients receiving care along the
same pathway and, in countries where there are aggre-
gated national data, the representativeness of the hos-
pital sample compared with all hospitals.
The economic evaluation will take a healthcare per-
spective of the costs and effects associated with the new
professional roles using a state-of-the-art economic evalu-
ation (including a Markov modelling exercise) and
MCDA. Only (changes in) costs within the healthcare
system and clinical effects will be considered. The ana-
lysis plan will exploit the size and variation in data across
all participating countries, and the comparability in level
of detail, completeness and quality of data across these
countries. The analyses will explore whether service
redesign leads to cost containment, investigate the
balance of cost and beneﬁts, and identify incentives for
policymakers when increased roles for the new profes-
sional roles are introduced.
Optimal models of care will be identiﬁed and the crit-
ical elements of these distinguished. The analysis is
aimed to identify optimal models for ‘best’ care deliv-
ered cost effectively. It will present examples of care inte-
gration and of the costs associated with ﬁnancing these
pathways. It will suggest solutions to barriers identiﬁed at
organisational and team level that are informed by
examples of good practice using standard theoretical
models.
Finally, a workforce planning model for each care
pathway will be developed reﬂecting the dynamic inter-
action between the number and type of health profes-
sionals (allowing for different approaches to labour
substitution), and the quality and cost of care for
patients and projected patient need. Algorithms and
computer modelling will be used to develop the ﬁnal
tool. The information requirements of the planning
models will be detailed, and the methodological and
data improvements required for improved workforce
planning models will be distinguished.
The models so developed will enable workforce plan-
ners to optimise care delivery along care pathways, taking
into account the needs of the population, the tasks
required to deliver care to meet these needs, and the avail-
ability (actual and potential) of various health professions
with the competences to deliver these tasks. Service provi-
ders will be able to benchmark against these to evaluate
the efﬁciency of existing provision and identify the modiﬁ-
able areas offering the largest efﬁciency gains.
DISCUSSION
In most healthcare teams, roles of healthcare professionals
are evolving in different ways. Some traditional roles are
being extended, new healthcare professions are being
introduced, tasks are being delegated from or substituted
by one professional to another, and new roles evolve as
new technologies are introduced. The nature and detail of
Figure 1 Potential DCE attributes/characteristics, descriptors and levels.
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this delegation has not been previously documented, and
the clinical and cost effectiveness of the new healthcare
workforce conﬁgurations has not been systematically
explored. Our hypotheses are that increasing skill mix in
this way is likely to be cost effective and that there is poten-
tial for wider implementation of these workforce conﬁg-
urations. Our main objective is to inform evidence-based
workforce planning.
The current research evidence suggests that new pro-
fessional roles can help improve access to care and the
quality of care.3 19 20 The greater deployment of new pro-
fessional roles could facilitate increased ﬂexibility, and
offer new solutions to the challenges of delivering health-
care to populations with changing and escalating needs.
Existing research has failed to show how changing skill
mix enhances or inhibits the integration of care within
and between organisations, and has largely focused on
process rather than clinical outcome measures. It has
failed to benchmark best practices regarding the compos-
ition of healthcare teams and has also failed to show the
effects on care as the new professional roles change care
processes and care pathways. There appears to be little
robust evidence of how new professional roles might
reduce the costs of healthcare services, and no evidence
of the impact on efﬁciency of care. We will ﬁll these
lacunae.
DISSEMINATION AND ETHICS
Dissemination
Each partner will produce a Country Report on Service
Design and Professional Roles which will include an analysis
of basic descriptive statistics by country and care pathway.
The Country Reports will serve as the basis for producing
a Country Brieﬁng Paper for each country studied. This will
inform key stakeholders and policymakers in each
country of the initial, country-speciﬁc ﬁndings from the
project. A Cross-Country Report will also be produced
drawing wider conclusions by comparing and contrasting
across the different health systems. A Europe-wide stake-
holder meeting for invited policymakers, workforce plan-
ners and academics will be held near the end of the
project. A ﬁnal report will be submitted to the EC and
will be available on the MUNROS project website. In add-
ition, ﬁndings will be presented at appropriate national
and international clinical, health services research and
health workforce conferences, and publications submitted
to peer-reviewed journals in these same ﬁelds.
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